期刊文献+

卵巢癌紫杉醇耐药细胞株OC_3/PIX_3及OC_3/PIX_5的比较基因组杂交研究 被引量:1

Comparative genomic hybridization study of two paclitaxel resistant ovarian carcinoma cell lines OC_3/PIX_3 and OC_3/PIX_5.
下载PDF
导出
摘要 目的:了解两种卵巢癌紫杉醇耐药株(OC3/PIX3及OC3/PIX5)和其亲代细胞紫杉醇敏感株(OC3)染色体DNA拷贝数的差异变化,探讨耐药细胞的分子遗传学改变。方法:运用比较基因组杂交(comparative genom ic hybrid ization,CGH)技术,将OC3/PIX3及OC3/PIX5与其亲代细胞株OC3的染色体基因组进行比较分析。结果:3种细胞株的染色体2pter-p21、3q、5p、9均有遗传物质表达增加;10号染色体表达增加仅见于OC3。染色体1,4,6的遗传物质在3种细胞株的表达均有减少。3p的减少发生在OC3和OC3/PIX5。仅在OC3细胞中见到7q、8p减少。OC3和OC3/PIX5出现染色体10q22过度扩增。最有意义的变化是OC3/PIX3细胞染色体2p22的过度扩增。结论:2p22拷贝数过度扩增可能与卵巢癌紫杉醇耐药相关。 Objective: To investigate the difference of DNA copy number on chromsomes and the molecular genetic alterations among, two paclitaxel-resistant ovarian carcinoma cell lines OC3/PIX3 and OC3/PIX5 , and their parent cell line OC3 which was sensitive to paclitaxel. Method:Comparative genomic hybridization was performed on OC3/PIX3 , OC3/PIX5, and OC3. Results:Gains of 2pter-p21,3q,5p,and 9 were detected in all three cell lines. Gain of 10 was only observed in OC3. Losses of chromosomes 1,4, and 6 were detected in all three cell lines. Loss of 3p was detected in OC3 and OC3/PIX3. Losses of 7q and 8p were only observed in OC3. Amplification (high-copy-number gain) of 10q22 was observed in OC3 and OC3/PIX5. The most interesting finding was that amplification of 2p22 was only detected in OC3/PIX3. Conclusion:Ampification of 2p22 may be associated with paclitaxel-resistantce in ovarian car- cinoma cell lines.
出处 《现代妇产科进展》 CSCD 北大核心 2005年第6期445-447,共3页 Progress in Obstetrics and Gynecology
基金 首都医学发展科研基金(重点学科)资助项目(首都ZD199915)
关键词 卵巢肿瘤 紫杉醇 耐药细胞系 基因组杂交 Ovarian neoplasms Paclitaxel(taxol) -resistant cell lines Comparative genomic hybridization
  • 相关文献

参考文献7

  • 1Takafumi Watanabe,Issei Imoto,Yoshinori,et al.A novel amplification at 17q21-23 in ovarian cancer cell lines detected by comparative genomic hybridization[J].Gynecol Oncol,2001,81:172-177.
  • 2Struski S,Doco-Fenzy M,Koehler M,et al.Cytogenetic evolution of human ovarian cell lines associated with chemoresistance and loss of tumorigenicity[J].Anal Cell Pathol,2003,25:115-122.
  • 3Takano M,Kudo K,Goto T,et al.Analyses by comparative genomic hybridization of genes relating with cisplatin-resistance in ovarian cancer[J].Hum Cell,2001,14(4):267-271.
  • 4Marion K,Anja J,Ulrike S,et al.Comparative genomic hybridization detects genetic imbalences in primary ovarian carcinoma as correlated with grade of differentiation[J].Cancer,2001,91(3):534-540.
  • 5Gonosuke S,Juan P,Stanislas du M,et al.Comparative genomic hybridization detects frequent over representation of chromosomal material from 3q26,8q24,and 20q13 in human ovarian carcinomas[J].Genes Chromosomes Cancer,1997,20:320-328.
  • 6Marcelis CL,van der Putten HW,et al.Chemotherapy resistant ovarian cancer in carriers of an hMSH2 mutation[J]?Fam Cancer,2001,1(2):107-109.
  • 7De las Alas MM,Los G,Lin X,et al.Identification of transdominant-negative genetic suppressor elements derived from hMSH2 that mediate resistance to 6-thioguanine[J].Mol Pharmacol,2002,62(5):1198-1206.

同被引文献13

  • 1Cheng SH, Tsai SY, Yen KL, et al. Concomitant radiotherapy and chemotherapy for early-stage nasopharyngeal carcinoma[J]. J Clin Oncol, 2000, 18(10): 2040-2045.
  • 2Isobe K, Uno T, Aruga T, et al. Weekly cisplatin administration concurrent with radiation therapy for locoregionally advanced naso- pharyngeal carcinoma[J]. IntJ Clin Oncol, 2005, 10(3): 201-203.
  • 3Kallioniemi A, Kallioniemi OP, Sudar D, et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors [J]. Science, 1992, 258(5083): 818-821.
  • 4Or Y, Chung GT, Tok F, et al. Identification of a novel 12p13.3 amplicon in nasopharyngeal carcinoma[J]. J Pathol, 2010, 220(1): 97-107.
  • 5Sizhong Z, Xiukung G, Yi Z. Cytogenetic studies on an epithelial cell line derived from poorly Differentiated nasopharyngeal carcinoma[J]. IntJ Cancer, 1983, 31(5): 578-590.
  • 6McDonald SL, Stevenson DA, Moira SE, et al. Genomic changes identi fi ed by comparative genomic hybridisation in docetaxel-resistant breast cancer cell lines[J]. EurJ Cancer, 2005, 41(7): 1086-1094.
  • 7Wang LD, Qin YR, Fan ZM, et al. Comparative genomic hybridization: comparison between esophageal squamous cell carcinoma and gastric cardia adenocarcinoma from a highincidence area for both cancers in Henan, northern China[J]. Dis Esophagus, 2006, 19(6): 459-467.
  • 8Walker LC, Harris GC, WellsJE, et al. Association of chromosome band 8q22 copy number gain with high grade invasive breast carcinomas by assessment of core needle biopsies[]]. Genes Chromo- somes Cancer, 2008, 47(5): 405-417.
  • 9Ribeiro FR, Jeronimo C, Henrique R, et al. 8q gain is an independent predictor of poor survival in diagnostic needle biopsies from prostate cancer suspects[J]. Clin Cancer Res, 2006, 12(13):3961-3970.
  • 10Unnnanni R, Teller S, Junker H, et al. Altered expression of tumor protein D52 regulates apoptosis and migration of prostate cancercells[J]. FEBS, 2008, 275(22):5703-5713.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部